Skip to main
VRDN
VRDN logo

Viridian Therapeutics (VRDN)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Viridian Therapeutics (VRDN) Stock

About Viridian Therapeutics (VRDN)

Viridian Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include Cobomarsen, which treats patients with certain cancers, including cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma, and Remlarsen and MRG-229, which are made for the treatment of patients with pathological f...read more
Market cap$1.3B
Yesterday's volume828.52K
Revenue (TTM)$302K
Avg. daily volume869.2K
EBITDA (TTM)-$335.69M
Open$16.02
Price / earnings ratio-3.92x
Yesterday's range$15.52 - $16.05
Debt / equity3.82x
52 week range$9.9 - $27.2
5 year debt / equity1.99x
Beta (LTM)1.09x
Interest coverage-98.17x
Dividend & yield$0.00 (0.00%)
Current ratio19.49x
Ex-dividend date
Next earningsAug 7, 2025
Dividend payable date

Viridian Therapeutics Stock Rating

What analysts recommend for VRDN stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 40%
Buy 47%
Hold 13%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 16, 2025, the market cap for VRDN stock is $1.3B

The current P/E ratio for VRDN stock is -3.92

The 52-week high for VRDN stock is $27.20. The current VRDN stock price $undefined is 100.00% below its 52-week high

The 52-week low for VRDN stock is $9.90. The current VRDN stock price $undefined has increased 100.00% from its 52-week low

No, the VRDN stock does not pay dividends to its shareholders

The target price for VRDN stock is $38.27 based on the average of what a group of analyst think VRDN stock could be worth at a future date. This is not a prediction by Public.com

How to buy VRDN stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in VRDN stock

    Navigate to the Explore page. Then, type VRDN into the search bar. When you see VRDN stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased VRDN stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Viridian Therapeutics Stock Earnings

The value each VRDN share was expected to gain vs. the value that each VRDN share actually gained.

Viridian Therapeutics (VRDN) reported Q1 2025 earnings per share (EPS) of -$0.87, beating estimates of -$0.96 by 9.37%. In the same quarter last year, Viridian Therapeutics's earnings per share (EPS) was -$0.79. Viridian Therapeutics is expected to release next earnings on 08/07/2025, with an earnings per share (EPS) estimate of $0.

Buy Viridian Therapeutics (VRDN) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.